What does NMTC's Q1 2025 EPS tell investors?
4/8/2025 08:25pm
NeuroOne Medical Technologies (NMTC) reported an EPS of $0.06 for the first quarter of 2025. This positive EPS indicates that the company was profitable during the period, which could be a sign of its business operations running smoothly and potentially a positive catalyst for the stock. However, it's important to consider other financial metrics and market conditions before drawing any definitive conclusions.
|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|NMTC|NMTC.O|NeuroOne Medical|2024 Q2|47.61904761904761|-0.11|186|
|NMTC|NMTC.O|NeuroOne Medical|2024 Q3|50|-0.1|186|
|NMTC|NMTC.O|NeuroOne Medical|2025 Q1|142.85714285714286|0.06|186|